mebudipine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2015
01219972015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Myocardial infarction (MI) is the acute condition of necrosis in myocardium which occurs as a result of imbalance… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Mebudipine is a new dihydropyridine calcium channel blocker, synthesized in our laboratory, for treatment of hypertension. It has… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
In the present study, we investigated the effects of mebudipine and dibudipine, two new Ca(2+) channel blockers, on primary… (More)
Is this relevant?
2008
2008
The protective effect of two new L-type calcium-channel blockers, mebudipine and dibudipine on neurotoxic effects induced by… (More)
Is this relevant?
2007
2007
Mebudipine and dibudipine are two newly synthesized dihydropyridine (DHP) calcium channel blockers that have been shown to have… (More)
Is this relevant?
2004
2004
The prototype 1,4-dihydropyridine (1,4-DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has… (More)
Is this relevant?
2004
2004
In previous studies, mebudipine, a newly synthesized dihydropyridine calcium channel blocker, showed a considerable vasoselective… (More)
Is this relevant?
2001
2001
PURPOSE To develop a high performance liquid chromatography system for the determination of a new 1,4-dihydropyridine, mebudipine… (More)
Is this relevant?
1999
1999
Mebudipine and dibudipine are two new dihydropyridine calcium-channel blockers that have been synthesized in our laboratory. In a… (More)
Is this relevant?
1997
1997
Dihydropyridine derivative calcium-channel blockers are widely used in the therapy of hypertension, angina pectoris and other… (More)
Is this relevant?